-
Should All Kids With Cancer Get Genetic Testing?
Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.
by Marcus A. Banks
-
A Drive for Diversity
African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.
by Jon Kelvey
-
Treating Cancer Patients With COVID-19: A New York City Experience
An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
-
Life After Pediatric Brain Cancer
Survivors of pediatric brain or spinal cord tumors can have cognitive and physical impairments. Researchers say that these deficits can be minimized with the right interventions.
by Cheryl Platzman Weinstock
-
Bill Aims to Improve Childhood Cancer Research
The STAR Act passes in the U.S. House of Representatives.
by Brad Jones
-
A Focus on Pediatric Cancer Screening
The AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes.
by Garrett M. Brodeur
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore